Judge Blocks RFK Jr. Vaccine Overhaul
Analysis based on 22 articles · First reported Mar 16, 2026 · Last updated Mar 17, 2026
The judge's ruling provides clarity for vaccine makers like Pfizer, BioNTech, Moderna, Merck & Co., Sanofi, and GSK plc, as it temporarily restores the previous vaccine recommendations and the integrity of the United States — Advisory Committee on Immunization Practices. This could lead to increased confidence in the U.S. vaccine policy, potentially stabilizing or positively impacting the stock prices of these pharmaceutical companies. However, the United States — United States Department of Health and Human Services plans to appeal, indicating continued uncertainty.
A federal judge, Brian Murphy, has temporarily blocked key parts of Robert F. Kennedy Jr.'s efforts to reshape U.S. vaccine policy. The ruling halts an order by Robert F. Kennedy Jr., as the United States — United States Department of Health and Human Services Secretary, to end broad recommendations for childhood vaccines against several diseases, including flu and hepatitis. Judge Brian Murphy also ruled that Robert F. Kennedy Jr.'s reconstitution of the United States — Advisory Committee on Immunization Practices, where he fired all 17 members and replaced them with individuals aligned with anti-vaccine views, likely violated federal law. Consequently, the appointments and all decisions made by the reformed committee were put on hold, leading to the postponement of a scheduled meeting. The American Academy of Pediatrics and other medical groups had amended a lawsuit, successfully arguing that the United States — United States Department of Health and Human Services and the United States — Centers for Disease Control and Prevention acted unlawfully in changing the immunization schedule without proper consultation and that the committee was unlawfully constituted. The Trump administration, under which Robert F. Kennedy Jr. was appointed, is expected to appeal the decision. This event has significant implications for public health policy and the pharmaceutical industry.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard